Last Updated:
Name Designation Appointment Date Status
Balachandra Reddy Duvuru

Appointed as Director since January 1998

Director 19-Jan-1998 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Rajagopala Reddy Duvvuru

Appointed as Managing Director since July 2003

Managing Director 01-Jul-2003 Current
Duvvuru Abhiram

Appointed as Director since February 2018

Director 05-Feb-2018 Current

People Timeline

Explore the timeline of key personnel in Erythro Pharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address Flat No.212, Bhanu Enclave, Near E.S.I. Hospital, Erragadda,, Hyderabad Telangana, 500038, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Erythro Pharma Private Limited?
You can contact Erythro Pharma Private Limited through their registered address at Flat No.212, Bhanu Enclave, Near E.S.I. Hospital, Erragadda,, Hyderabad Telangana, 500038, India, or via their website at erythropharma.com. Social media links are also provided where applicable.
Who are the current directors of Erythro Pharma Private Limited?
The current directors of Erythro Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • BALACHANDRA REDDY DUVURU
  • RAJAGOPALA REDDY DUVVURU
  • DUVVURU ABHIRAM
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available